 1. Patients must have a histologically verified diagnosis of neuroblastoma, Wilms tumor, or sarcoma, including rhabdomyosarcoma, a Ewings sarcoma family tumor ES, PNET, synovial sarcoma, fibrosarcoma, or desmoplastic round cell tumor. 